-
Notifications
You must be signed in to change notification settings - Fork 17
Expand file tree
/
Copy pathdatasets_xvalidation.csv
More file actions
We can make this file beautiful and searchable if this error is corrected: No commas found in this CSV file in line 0.
504 lines (504 loc) · 30.7 KB
/
datasets_xvalidation.csv
File metadata and controls
504 lines (504 loc) · 30.7 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
Slide;Dataset;Tumor;Scanner;Origin;Species
1;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
2;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
3;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
4;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
5;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
6;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
7;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
8;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
9;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
10;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
11;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
12;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
13;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
14;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
15;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
16;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
17;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
18;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
19;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
20;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
21;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
22;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
23;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
24;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
25;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
26;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
27;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
28;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
29;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
30;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
31;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
32;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
33;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
34;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
35;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
36;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
37;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
38;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
39;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
40;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
41;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
42;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
43;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
44;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
45;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
46;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
47;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
48;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
49;train;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
50;test;human breast cancer;Hamammatsu XR;UMC Utrecht;Human
51;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
52;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
53;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
54;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
55;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
56;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
57;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
58;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
59;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
60;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
61;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
62;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
63;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
64;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
65;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
66;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
67;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
68;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
69;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
70;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
71;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
72;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
73;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
74;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
75;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
76;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
77;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
78;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
79;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
80;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
81;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
82;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
83;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
84;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
85;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
86;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
87;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
88;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
89;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
90;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
91;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
92;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
93;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
94;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
95;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
96;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
97;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
98;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
99;train;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
100;test;human breast cancer;Hamamatsu S360;UMC Utrecht;Human
101;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
102;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
103;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
104;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
105;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
106;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
107;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
108;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
109;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
110;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
111;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
112;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
113;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
114;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
115;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
116;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
117;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
118;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
119;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
120;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
121;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
122;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
123;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
124;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
125;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
126;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
127;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
128;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
129;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
130;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
131;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
132;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
133;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
134;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
135;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
136;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
137;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
138;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
139;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
140;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
141;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
142;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
143;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
144;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
145;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
146;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
147;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
148;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
149;train;human breast cancer;Aperio CS2;UMC Utrecht;Human
150;test;human breast cancer;Aperio CS2;UMC Utrecht;Human
201;train;canine lung cancer;3D Histech;VMU Vienna;Canine
202;train;canine lung cancer;3D Histech;VMU Vienna;Canine
203;test;canine lung cancer;3D Histech;VMU Vienna;Canine
204;train;canine lung cancer;3D Histech;VMU Vienna;Canine
205;train;canine lung cancer;3D Histech;VMU Vienna;Canine
206;train;canine lung cancer;3D Histech;VMU Vienna;Canine
207;train;canine lung cancer;3D Histech;VMU Vienna;Canine
208;train;canine lung cancer;3D Histech;VMU Vienna;Canine
209;train;canine lung cancer;3D Histech;VMU Vienna;Canine
210;train;canine lung cancer;3D Histech;VMU Vienna;Canine
211;train;canine lung cancer;3D Histech;VMU Vienna;Canine
212;test;canine lung cancer;3D Histech;VMU Vienna;Canine
213;train;canine lung cancer;3D Histech;VMU Vienna;Canine
214;train;canine lung cancer;3D Histech;VMU Vienna;Canine
215;train;canine lung cancer;3D Histech;VMU Vienna;Canine
216;train;canine lung cancer;3D Histech;VMU Vienna;Canine
217;train;canine lung cancer;3D Histech;VMU Vienna;Canine
218;test;canine lung cancer;3D Histech;VMU Vienna;Canine
219;train;canine lung cancer;3D Histech;VMU Vienna;Canine
220;test;canine lung cancer;3D Histech;VMU Vienna;Canine
221;train;canine lung cancer;3D Histech;VMU Vienna;Canine
222;train;canine lung cancer;3D Histech;VMU Vienna;Canine
223;train;canine lung cancer;3D Histech;VMU Vienna;Canine
224;train;canine lung cancer;3D Histech;VMU Vienna;Canine
225;train;canine lung cancer;3D Histech;VMU Vienna;Canine
226;train;canine lung cancer;3D Histech;VMU Vienna;Canine
227;train;canine lung cancer;3D Histech;VMU Vienna;Canine
228;train;canine lung cancer;3D Histech;VMU Vienna;Canine
229;train;canine lung cancer;3D Histech;VMU Vienna;Canine
230;test;canine lung cancer;3D Histech;VMU Vienna;Canine
231;train;canine lung cancer;3D Histech;VMU Vienna;Canine
232;test;canine lung cancer;3D Histech;VMU Vienna;Canine
233;train;canine lung cancer;3D Histech;VMU Vienna;Canine
234;test;canine lung cancer;3D Histech;VMU Vienna;Canine
235;train;canine lung cancer;3D Histech;VMU Vienna;Canine
236;test;canine lung cancer;3D Histech;VMU Vienna;Canine
237;train;canine lung cancer;3D Histech;VMU Vienna;Canine
238;train;canine lung cancer;3D Histech;VMU Vienna;Canine
239;test;canine lung cancer;3D Histech;VMU Vienna;Canine
240;train;canine lung cancer;3D Histech;VMU Vienna;Canine
241;test;canine lung cancer;3D Histech;VMU Vienna;Canine
242;train;canine lung cancer;3D Histech;VMU Vienna;Canine
243;train;canine lung cancer;3D Histech;VMU Vienna;Canine
244;train;canine lung cancer;3D Histech;VMU Vienna;Canine
245;train;canine lymphoma;3D Histech;VMU Vienna;Canine
246;train;canine lymphoma;3D Histech;VMU Vienna;Canine
247;train;canine lymphoma;3D Histech;VMU Vienna;Canine
248;train;canine lymphoma;3D Histech;VMU Vienna;Canine
249;test;canine lymphoma;3D Histech;VMU Vienna;Canine
250;train;canine lymphoma;3D Histech;VMU Vienna;Canine
251;test;canine lymphoma;3D Histech;VMU Vienna;Canine
252;test;canine lymphoma;3D Histech;VMU Vienna;Canine
253;test;canine lymphoma;3D Histech;VMU Vienna;Canine
254;train;canine lymphoma;3D Histech;VMU Vienna;Canine
255;train;canine lymphoma;3D Histech;VMU Vienna;Canine
256;test;canine lymphoma;3D Histech;VMU Vienna;Canine
257;test;canine lymphoma;3D Histech;VMU Vienna;Canine
258;train;canine lymphoma;3D Histech;VMU Vienna;Canine
259;train;canine lymphoma;3D Histech;VMU Vienna;Canine
260;train;canine lymphoma;3D Histech;VMU Vienna;Canine
261;train;canine lymphoma;3D Histech;VMU Vienna;Canine
262;train;canine lymphoma;3D Histech;VMU Vienna;Canine
263;train;canine lymphoma;3D Histech;VMU Vienna;Canine
264;train;canine lymphoma;3D Histech;VMU Vienna;Canine
265;train;canine lymphoma;3D Histech;VMU Vienna;Canine
266;train;canine lymphoma;3D Histech;VMU Vienna;Canine
267;train;canine lymphoma;3D Histech;VMU Vienna;Canine
268;test;canine lymphoma;3D Histech;VMU Vienna;Canine
269;test;canine lymphoma;3D Histech;VMU Vienna;Canine
270;train;canine lymphoma;3D Histech;VMU Vienna;Canine
271;train;canine lymphoma;3D Histech;VMU Vienna;Canine
272;train;canine lymphoma;3D Histech;VMU Vienna;Canine
273;train;canine lymphoma;3D Histech;VMU Vienna;Canine
274;train;canine lymphoma;3D Histech;VMU Vienna;Canine
275;train;canine lymphoma;3D Histech;VMU Vienna;Canine
276;test;canine lymphoma;3D Histech;VMU Vienna;Canine
277;train;canine lymphoma;3D Histech;VMU Vienna;Canine
278;train;canine lymphoma;3D Histech;VMU Vienna;Canine
279;train;canine lymphoma;3D Histech;VMU Vienna;Canine
280;train;canine lymphoma;3D Histech;VMU Vienna;Canine
281;train;canine lymphoma;3D Histech;VMU Vienna;Canine
282;train;canine lymphoma;3D Histech;VMU Vienna;Canine
283;train;canine lymphoma;3D Histech;VMU Vienna;Canine
284;train;canine lymphoma;3D Histech;VMU Vienna;Canine
285;train;canine lymphoma;3D Histech;VMU Vienna;Canine
286;train;canine lymphoma;3D Histech;VMU Vienna;Canine
287;train;canine lymphoma;3D Histech;VMU Vienna;Canine
288;train;canine lymphoma;3D Histech;VMU Vienna;Canine
289;train;canine lymphoma;3D Histech;VMU Vienna;Canine
290;train;canine lymphoma;3D Histech;VMU Vienna;Canine
291;test;canine lymphoma;3D Histech;VMU Vienna;Canine
292;test;canine lymphoma;3D Histech;VMU Vienna;Canine
293;train;canine lymphoma;3D Histech;VMU Vienna;Canine
294;train;canine lymphoma;3D Histech;VMU Vienna;Canine
295;test;canine lymphoma;3D Histech;VMU Vienna;Canine
296;train;canine lymphoma;3D Histech;VMU Vienna;Canine
297;train;canine lymphoma;3D Histech;VMU Vienna;Canine
298;train;canine lymphoma;3D Histech;VMU Vienna;Canine
299;train;canine lymphoma;3D Histech;VMU Vienna;Canine
300;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
301;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
302;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
303;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
304;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
305;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
306;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
307;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
308;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
309;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
310;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
311;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
312;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
313;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
314;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
315;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
316;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
317;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
318;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
319;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
320;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
321;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
322;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
323;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
324;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
325;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
326;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
327;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
328;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
329;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
330;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
331;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
332;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
333;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
334;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
335;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
336;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
337;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
338;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
339;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
340;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
341;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
342;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
343;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
344;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
345;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
346;test;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
347;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
348;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
349;train;canine cutaneous mast cell tumor;Aperio CS2;FU Berlin;Canine
350;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
351;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
352;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
353;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
354;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
355;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
356;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
357;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
358;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
359;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
360;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
361;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
362;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
363;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
364;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
365;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
366;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
367;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
368;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
369;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
370;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
371;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
372;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
373;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
374;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
375;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
376;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
377;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
378;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
379;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
380;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
381;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
382;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
383;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
384;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
385;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
386;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
387;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
388;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
389;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
390;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
391;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
392;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
393;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
394;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
395;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
396;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
397;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
398;test;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
399;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
400;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
401;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
402;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
403;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
404;train;human neuroendocrine tumor;Hamamatsu XR;UMC Utrecht;Human
405;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
406;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
407;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
408;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
409;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
410;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
411;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
412;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
413;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
414;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
415;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
416;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
417;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
418;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
419;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
420;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
421;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
422;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
423;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
424;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
425;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
426;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
427;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
428;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
429;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
430;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
431;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
432;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
433;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
434;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
435;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
436;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
437;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
438;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
439;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
440;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
441;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
442;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
443;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
444;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
445;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
446;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
447;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
448;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
449;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
450;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
451;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
452;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
453;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
454;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
455;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
456;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
457;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
458;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
459;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
460;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
461;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
462;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
463;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
464;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
465;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
466;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
467;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
468;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
469;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
470;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
471;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
472;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
473;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
474;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
475;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
476;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
477;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
478;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
479;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
480;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
481;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
482;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
483;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
484;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
485;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
486;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
487;test;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
488;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
489;train;canine soft tissue sarcoma;3D Histech;AMC New York;Canine
490;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
491;test;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
492;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
493;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
494;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
495;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
496;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
497;test;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
498;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
499;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
500;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
501;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
502;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
503;train;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
504;test;canine soft tissue sarcoma;3D Histech;VMU Vienna;Canine
505;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
506;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
507;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
508;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
509;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
510;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
511;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
512;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
513;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
514;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
515;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
516;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
517;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
518;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
519;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
520;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
521;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
522;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
523;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
524;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
525;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
526;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
527;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
528;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
529;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
530;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
531;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
532;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
533;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
534;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
535;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
536;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
537;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
538;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
539;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
540;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
541;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
542;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
543;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
544;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
545;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
546;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
547;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
548;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
549;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
550;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
551;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human
552;test;human melanoma;Hamamatsu XR;UMC Utrecht;Human
553;train;human melanoma;Hamamatsu XR;UMC Utrecht;Human